P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial

• Michael Oertel,
• Dominik Hering,
• Nina Nacke,
• Christopher Kittel,
• Kai Kröger,
• Jan Kriz,
• Michael Fuchs,
• Christian Baues,
• Dirk Vordermark,
• Rita Engenhart-Cabillic,
• Klaus Herfarth,
• Peter Lukas,
• Heinz Schmidberger,
• Simone Marnitz,
• Peter Borchmann,
• Andreas Engert,
• Uwe Haverkamp,
• Hans Theodor Eich

Affiliations

Michael Oertel

1 Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany

Dominik Hering

1 Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany

Nina Nacke

1 Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany

Christopher Kittel

1 Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany

Kai Kröger

1 Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany

Jan Kriz

2 Department of Radiation Oncology, Alexianer Clemenshospital Muenster, Muenster, Germany

Michael Fuchs

3 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Christian Baues

4 Department of Radiation Oncology and Cyberknife Center, University Hospital of Cologne, Cologne, Germany

Dirk Vordermark

5 Department of Radiation Oncology, University Hospital Halle (Saale), Halle (Saale), Germany

Rita Engenhart-Cabillic

6 Department of Radiotherapy and Radiation Oncology, University Hospital Giessen-Marburg, Marburg, Germany

Klaus Herfarth

7 Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany

Peter Lukas

8 Department of Radiooncology, Medical University Innsbruck, Innsbruck, Austria

Heinz Schmidberger

9 Department of Radiotherapy and Radiation Oncology, University Hospital Mainz, Mainz, Germany

Simone Marnitz

4 Department of Radiation Oncology and Cyberknife Center, University Hospital of Cologne, Cologne, Germany

Peter Borchmann

3 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Andreas Engert

3 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany

Uwe Haverkamp

1 Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany

Hans Theodor Eich

1 Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany